Aware that the place of hematology patients in national vaccination strategies is of increasing concern to many of you, we want to inform you that EHA has published two statements on its website:
• Recommendations for COVID-19 vaccination in patients with hematologic cancer (LINK)
• Recommendations for COVID-19 vaccination in patients with non-malignant diseases (LINK)
We would encourage you to share these with the health authorities in your country and urge them to:
1. Prioritize the vaccination of patients with hematologic malignancies.
2. Take into account the recommendations for specific groups of patients with non-malignant blood disorders.
Due to scarcity of data, no blanket vaccination strategy can be recommended for patients with non-malignant hematological diseases. EHA’s Scientific Working
Groups will be updating these recommendations once more evidence is available.
Patient-friendly versions of both statements are being prepared by the patient organizations and will be published on the EHA website soon.
Prof. John Gribben Prof. Elizabeth Macintyre